Influences on the quality of published drug studies.

@article{citeulike:961166, abstract = {To practice evidence-based medicine, physicians need data on the clinical effectiveness, toxicity, convenience, and cost of new drugs compared with available alternatives. We give examples of published drug studies that are defective, sometimes because pharmaceutical industry funding has affected their content and quality. We make recommendations on how to avoid these defects.}, address = {Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94109, USA.}, author = {Bero, L. A. and Rennie, D. }, citeulike-article-id = {961166}, issn = {0266-4623}, journal = {Int J Technol Assess Health Care}, keywords = {publication, quality}, number = {2}, pages = {209--237}, posted-at = {2006-11-24 21:25:34}, priority = {0}, title = {Influences on the quality of published drug studies.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/8707496}, volume = {12}, year = {1996} }

TY - JOUR ID - citeulike:961166 L3 - citeulike-article-id:961166 TI - Influences on the quality of published drug studies. JF - Int J Technol Assess Health Care VL - 12 IS - 2 SP - 209 EP - 237 AD - Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94109, USA. SN - 0266-4623 N2 - To practice evidence-based medicine, physicians need data on the clinical effectiveness, toxicity, convenience, and cost of new drugs compared with available alternatives. We give examples of published drug studies that are defective, sometimes because pharmaceutical industry funding has affected their content and quality. We make recommendations on how to avoid these defects. KW - publication KW - quality AU - Bero, LA AU - Rennie, D PY - 1996/// UR - http://view.ncbi.nlm.nih.gov/pubmed/8707496 ER -